RESUMEN
Spinal cord injury (SCI) can cause chronic paralysis and incontinence and remains a major worldwide healthcare burden, with no regenerative treatment clinically available. Intraspinal transplantation of olfactory ensheathing cells (OECs) and injection of chondroitinase ABC (chABC) are both promising therapies but limited and unpredictable responses are seen, particularly in canine clinical trials. Sustained delivery of chABC presents a challenge due to its thermal instability; we hypothesised that transplantation of canine olfactory mucosal OECs genetically modified ex vivo by lentiviral transduction to express chABC (cOEC-chABC) would provide novel delivery of chABC and synergistic therapy. Rats were randomly divided into cOEC-chABC, cOEC, or vehicle transplanted groups and received transplant immediately after dorsal column crush corticospinal tract (CST) injury. Rehabilitation for forepaw reaching and blinded behavioural testing was conducted for 8 weeks. We show that cOEC-chABC transplanted animals recover greater forepaw reaching accuracy on Whishaw testing and more normal gait than cOEC transplanted or vehicle control rats. Increased CST axon sprouting cranial to the injury and serotonergic fibres caudal to the injury suggest a mechanism for recovery. We therefore demonstrate that cOECs can deliver sufficient chABC to drive modest functional improvement, and that this genetically engineered cellular and molecular approach is a feasible combination therapy for SCI.
Asunto(s)
Condroitinasas y Condroitín Liasas/administración & dosificación , Mucosa Olfatoria/fisiología , Mucosa Olfatoria/trasplante , Recuperación de la Función/fisiología , Traumatismos de la Médula Espinal/enzimología , Traumatismos de la Médula Espinal/rehabilitación , Animales , Células Cultivadas , Condroitinasas y Condroitín Liasas/biosíntesis , Perros , Masculino , Mucosa Olfatoria/citología , Ratas , Ratas Wistar , Traumatismos de la Médula Espinal/patologíaRESUMEN
Inhibitory extracellular matrices form around mature neurons as perineuronal nets containing chondroitin sulfate proteoglycans that limit axonal sprouting after CNS injury. The enzyme chondroitinase (Chase) degrades inhibitory chondroitin sulfate proteoglycans and improves axonal sprouting and functional recovery after spinal cord injury in rodents. We evaluated the effects of Chase in rhesus monkeys that had undergone C7 spinal cord hemisection. Four weeks after hemisection, we administered multiple intraparenchymal Chase injections below the lesion, targeting spinal cord circuits that control hand function. Hand function improved significantly in Chase-treated monkeys relative to vehicle-injected controls. Moreover, Chase significantly increased corticospinal axon growth and the number of synapses formed by corticospinal terminals in gray matter caudal to the lesion. No detrimental effects were detected. This approach appears to merit clinical translation in spinal cord injury.
Asunto(s)
Condroitinasas y Condroitín Liasas/uso terapéutico , Traumatismos de la Médula Espinal/tratamiento farmacológico , Animales , Axones/patología , Condroitinasas y Condroitín Liasas/administración & dosificación , Condroitinasas y Condroitín Liasas/efectos adversos , Sustancia Gris/patología , Mano/inervación , Mano/fisiopatología , Inyecciones Intralesiones , Macaca mulatta , Masculino , Microglía/patología , Neuronas Motoras/patología , Desempeño Psicomotor , Tractos Piramidales/patología , Recuperación de la Función , Traumatismos de la Médula Espinal/fisiopatología , Porcinos , Sinapsis/patología , Resultado del TratamientoRESUMEN
Functional recovery following nerve injury declines when target re-innervation is delayed. Currently, no intervention exists to improve outcomes after prolonged denervation. We explored the neuroregenerative effects of glial cell line-derived neurotrophic factor (GDNF) and chondroitinase (CDN) in a chronic denervation animal model. A fibrin-based sustained delivery method for growth factors was optimized in vitro and in vivo, and then tested in our animal model. GDNF, CDN, and GDNF+CDN were injected into the denervated stump at the time of nerve repair. Histomorphometry and retrograde labeling were used to assess axonal regeneration. The mechanisms promoting such regeneration were explored with immunofluorescence. Five weeks after repair, the GDNF+CDN group had the highest number and maturity of axons. GDNF was noted to preferentially promote axonal maturity, whereas CDN predominantly increased the number of axons. GDNF favored motor neuron regeneration, and upregulated Ki67 in Schwann cells. CDN did not favor motor versus sensory regeneration and was noted to cleave inhibitory endoneurial proteoglycans. Early measures of nerve regeneration after delayed repair are improved by activating Schwann cells and breaking down the inhibitory proteoglycans in the distal nerve segment, suggesting a role for GDNF+CDN to be translated for human nerve repairs.
Asunto(s)
Axones/fisiología , Condroitinasas y Condroitín Liasas/administración & dosificación , Desnervación/métodos , Modelos Animales de Enfermedad , Factor Neurotrófico Derivado de la Línea Celular Glial/administración & dosificación , Regeneración Nerviosa/fisiología , Animales , Axones/efectos de los fármacos , Enfermedad Crónica , Sistemas de Liberación de Medicamentos/métodos , Quimioterapia Combinada , Femenino , Regeneración Nerviosa/efectos de los fármacos , Ratas , Ratas Sprague-DawleyRESUMEN
Hippocampal sharp wave ripples (SWRs) represent irregularly occurring synchronous neuronal population events that are observed during phases of rest and slow wave sleep. SWR activity that follows learning involves sequential replay of training-associated neuronal assemblies and is critical for systems level memory consolidation. SWRs are initiated by CA2 or CA3 pyramidal cells (PCs) and require initial excitation of CA1 PCs as well as participation of parvalbumin (PV) expressing fast spiking (FS) inhibitory interneurons. These interneurons are relatively unique in that they represent the major neuronal cell type known to be surrounded by perineuronal nets (PNNs), lattice like structures composed of a hyaluronin backbone that surround the cell soma and proximal dendrites. Though the function of the PNN is not completely understood, previous studies suggest it may serve to localize glutamatergic input to synaptic contacts and thus influence the activity of ensheathed cells. Noting that FS PV interneurons impact the activity of PCs thought to initiate SWRs, and that their activity is critical to ripple expression, we examine the effects of PNN integrity on SWR activity in the hippocampus. Extracellular recordings from the stratum radiatum of horizontal murine hippocampal hemisections demonstrate SWRs that occur spontaneously in CA1. As compared with vehicle, pre-treatment (120 min) of paired hemislices with hyaluronidase, which cleaves the hyaluronin backbone of the PNN, decreases PNN integrity and increases SWR frequency. Pre-treatment with chondroitinase, which cleaves PNN side chains, also increases SWR frequency. Together, these data contribute to an emerging appreciation of extracellular matrix as a regulator of neuronal plasticity and suggest that one function of mature perineuronal nets could be to modulate the frequency of SWR events.
Asunto(s)
Potenciales de Acción/fisiología , Espacio Extracelular/metabolismo , Hipocampo/metabolismo , Interneuronas/metabolismo , Animales , Condroitinasas y Condroitín Liasas/administración & dosificación , Condroitinasas y Condroitín Liasas/metabolismo , Femenino , Hipocampo/citología , Hialuronoglucosaminidasa/administración & dosificación , Hialuronoglucosaminidasa/metabolismo , Interneuronas/citología , Masculino , Ratones Endogámicos C57BL , Ratones Transgénicos , Modelos Neurológicos , Parvalbúminas/genética , Parvalbúminas/metabolismo , Técnicas de Cultivo de TejidosRESUMEN
Vitreomacular traction occurs due to incomplete or anomalous posterior vitreous detachment. Over time, the vitreous pulls anteriorly and causes retinal distortion and eventually reduced vision. Traditionally, vitreomacular traction was treated with vitrectomy surgery. In the past few years, there is a paradigm shift towards pharmacologic vitreolysis, which involves the intravitreal injection of enzymatic and non-enzymatic agents that facilitate posterior vitreous detachment. Many agents have been investigated and trialled including plasmin, microplasmin (Ocriplasmin), hyaluronidase, nattokinase, chondroitinase and dispase. This review will focus on the progress and current status in this research.
Asunto(s)
Condroitinasas y Condroitín Liasas/metabolismo , Endopeptidasas/metabolismo , Fibrinolisina/metabolismo , Hialuronoglucosaminidasa/metabolismo , Subtilisinas/metabolismo , Desprendimiento del Vítreo/terapia , Animales , Condroitinasas y Condroitín Liasas/administración & dosificación , Endopeptidasas/administración & dosificación , Fibrinolisina/administración & dosificación , Humanos , Hialuronoglucosaminidasa/administración & dosificación , Inyecciones Intravítreas , Subtilisinas/administración & dosificación , Tracción , Desprendimiento del Vítreo/metabolismo , Desprendimiento del Vítreo/cirugíaRESUMEN
STUDY DESIGN: We evaluated whether combination of chondroitinase (chABC) administration and brain-derived neurotrophic factor (BDNF)-mesenchymal stem cell (MSC) transplantation could provide an optimal effect for the treatment of spinal cord injury (SCI) subjected to complete transection. OBJECTIVES: Behavioral assessments and DBA tracing were used to evaluate the effects of combination of chABC administration and BDNF-MSC transplantation on axonal regeneration and functional improvement in SCT rats. SETTING: Sichuan, ChinaMethods:Bone mesenchymal stem cells (BMSCs) were cultured and overexpressed BDNF recombinant vector was constructed into MSCs, then transplanted into the impaired spinal cord, together with chABC administration. Finally, the cortical spinal tract regeneration was detected by DBA tracing at 4 weeks post operation, and the expression of nerve growth factor (NGF), BDNF, neurotrophic factor (NT)-3, NT-4, fibroblast growth factor (FGF-2)-2, B cell lymphoma 2 (BCL-2) assaciated X protein (BAX) and BCL-2 in the caudal cord tissues was assessed by reverse transcription-PCR. RESULTS: Animals received both BDNF-BMSC transplantation and chABC administration presented the best functional recovery and obvious axonal regeneration. Moreover, NGF expression was significantly higher than that in the other groups. CONCLUSION: Co-treated strategy could effectively promote motor functional recovery and axonal regeneration in SCT rats associated with NGF upregulation.
Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/metabolismo , Condroitinasas y Condroitín Liasas/administración & dosificación , Trasplante de Células Madre Mesenquimatosas/métodos , Factor de Crecimiento Nervioso/metabolismo , Fármacos Neuroprotectores/administración & dosificación , Traumatismos de la Médula Espinal/terapia , Animales , Trasplante de Médula Ósea/métodos , Factor Neurotrófico Derivado del Encéfalo/genética , Células Cultivadas , Modelos Animales de Enfermedad , Femenino , Células Madre Mesenquimatosas/metabolismo , Regeneración Nerviosa/fisiología , Técnicas de Trazados de Vías Neuroanatómicas , Ratas , Recuperación de la Función/fisiología , Médula Espinal/metabolismo , Médula Espinal/patología , Traumatismos de la Médula Espinal/metabolismo , Traumatismos de la Médula Espinal/patología , TransfecciónRESUMEN
The endothelial glycocalyx is well endowed with the glycosaminoglycans (GAGs) heparan sulfate, chondroitin sulfate and hyaluronan. The current studies aimed to assess the relative contributions of each of these GAGs to the thickness and permeability of the glycocalyx layer by direct enzymatic removal of each using micropipettes to infuse heparinase, chondroitinase and hyaluronidase into post-capillary venules of the intestinal mesentery of the rat. The relative losses of GAGs due to enzymatic removal were compared with stimulated shedding of glycans induced by superfusing the mesentery with 10(-)(7)M fMLP. Thickness of the glycocalyx was assessed by infiltration of the glycocalyx with circulating FITC labeled 70kDa dextran (Dx70) and measuring the distance from the dye front to the surface of the endothelium (EC), which averaged 463nm under control conditions. Reductions in thickness were 43.3%, 34.1% and 26.1% following heparinase, chondroitinase and hyaluronidase, respectively, and 89.7% with a mixture of all three enzymes. Diffusion coefficients of FITC in the glycocalyx were determined using a 1-D diffusion model. By comparison of measured transients in radial intensity of a bolus of FITC with that of a computational model a diffusion coefficient D was obtained. Values of D were obtained corresponding to the thickness of the layer demarcated by Dx70 (D(Dx70)), and a smaller sublayer 173nm above the EC surface (D(173)), prior to and following enzyme infusion and superfusion with fMLP. The magnitude of D(Dx70) was twice that of D(173) suggesting that the glycocalyx is more compact near the EC surface. Chondroitinase and hyaluronidase significantly increased both D(Dx70) and D(173). However, heparinase decreased D(Dx70), and did not induce any significant change for the D(173). These observations suggest that the three GAGs are not evenly distributed throughout the glycocalyx and that they each contribute to permeability of the glycocalyx to a differing extent. The fMLP-induced shedding caused a reduction in glycocalyx thickness (which may increase permeability) and as with heparinase, decreased the diffusion coefficient of solutes (which may decrease permeability). This behavior suggests that the removal of heparan sulfate may cause a collapse of the glycocalyx which counters decreases in thickness by compacting the layer to maintain a constant resistance to filtration.
Asunto(s)
Permeabilidad de la Membrana Celular , Células Endoteliales/metabolismo , Glicocálix/metabolismo , Glicosaminoglicanos/metabolismo , Mesenterio/irrigación sanguínea , Animales , Sulfatos de Condroitina/metabolismo , Condroitinasas y Condroitín Liasas/administración & dosificación , Simulación por Computador , Dextranos/metabolismo , Difusión , Células Endoteliales/ultraestructura , Fluoresceína-5-Isotiocianato/análogos & derivados , Fluoresceína-5-Isotiocianato/metabolismo , Colorantes Fluorescentes/metabolismo , Glicocálix/ultraestructura , Liasa de Heparina/administración & dosificación , Heparitina Sulfato/metabolismo , Ácido Hialurónico/metabolismo , Hialuronoglucosaminidasa/administración & dosificación , Inflamación/metabolismo , Infusiones Intravenosas , Masculino , Modelos Cardiovasculares , N-Formilmetionina Leucil-Fenilalanina/administración & dosificación , Ratas , Ratas Wistar , Vénulas/metabolismoRESUMEN
Due to the varied and numerous changes in spinal cord tissue following injury, successful treatment for repair may involve strategies combining neuroprotection (pharmacological prevention of some of the damaging intracellular cascades that lead to secondary tissue loss), axonal regeneration promotion (cell transplantation, genetic engineering to increase growth factors, neutralization of inhibitory factors, reduction in scar formation), and rehabilitation. Our goal has been to find effective combination strategies to improve outcome after injury to the adult rat thoracic spinal cord. Combination interventions tested have been implantation of Schwann cells (SCs) plus neuroprotective agents and growth factors administered in various ways, olfactory ensheathing cell (OEC) implantation, chondroitinase addition, or elevation of cyclic AMP. The most efficacious strategy in our hands for the acute complete transection/SC bridge model, including improvement in locomotion [Basso, Beattie, Bresnahan Scale (BBB)], is the combination of SCs, OECs, and chondroitinase administration (BBB 2.1 vs 6.6, 3 times more myelinated axons in the SC bridge, increased serotonergic axons in the bridge and beyond, and significant correlation between the number of bridge myelinated axons and functional improvement). We found the most successful combination strategy for a subacute spinal cord contusion injury (12.5-mm, 10-g weight, MASCIS impactor) to be SCs and elevation of cyclic AMP (BBB 10.4 vs 15, significant increases in white matter sparing, in myelinated axons in the implant, and in responding reticular formation and red and raphe nuclei, and a significant correlation between the number of serotonergic fibers and improvement in locomotion). Thus, in two injury paradigms, these combination strategies as well as others studied in our laboratory have been found to be more effective than SCs alone and suggest ways in which clinical application may be developed.
Asunto(s)
Condroitinasas y Condroitín Liasas/administración & dosificación , Nervio Olfatorio/citología , Células de Schwann/trasplante , Traumatismos de la Médula Espinal/terapia , Animales , AMP Cíclico/metabolismo , Humanos , Recuperación de la Función/efectos de los fármacos , Recuperación de la Función/fisiología , Traumatismos de la Médula Espinal/metabolismoRESUMEN
At present, surgical separation of the vitreous from the retina (posterior vitreous detachment, PVD) is achieved by mechanical means only. However, with this technique, complete removal of the cortical vitreous from the internal limiting membrane of the retina is not feasible. As incomplete PVD and an attached vitreous cortex are associated with the progression of common retinal diseases including diabetic retinopathy and maculopathy, central retinal vein occlusion and proliferative vitreoretinopathy, induction of complete PVD is a major issue both in vitreoretinal surgery and in medical retina. This chapter focuses on current concepts of pharmacologic vitreolysis. Agents capable of altering the molecular organization of the vitreous are introduced and discussed in terms of PVD induction and liquefaction of the vitreous gel.
Asunto(s)
Condroitinasas y Condroitín Liasas/uso terapéutico , Endopeptidasas/uso terapéutico , Fibrinolisina/uso terapéutico , Hialuronoglucosaminidasa/uso terapéutico , Enfermedades de la Retina/tratamiento farmacológico , Cuerpo Vítreo/efectos de los fármacos , Condroitinasas y Condroitín Liasas/administración & dosificación , Endopeptidasas/administración & dosificación , Fibrinolisina/administración & dosificación , Fibrinolíticos/administración & dosificación , Fibrinolíticos/uso terapéutico , Humanos , Hialuronoglucosaminidasa/administración & dosificación , Inyecciones , Resultado del TratamientoRESUMEN
The aim of using enzymes in vitreoretinal surgery is to facility PVD and create pharmacological vitrectomy. It can be achieved by liquefying the gel structure of the vitreous (synchisis) and weakening of adherence of the posterior vitreous cortex to retina (syneresis). The article reviews currently used enzymes in vitreoretinal surgery (plasmin, hyaluronidase, dispase, chondroitinase, collagenase, urokinase, TPA--tissue plasminogen activator) and presents potential profits and side-effects related to their use. Although the day when vitreous surgery is replaced by pharmacological vitreolisis remains still as a future, these enzymes hold great promise. Additionally it has been proved that enzymes can be used successfully as an intraoperative adjuvant in vitrectomy.
Asunto(s)
Enzimas/administración & dosificación , Oftalmopatías/cirugía , Retina/cirugía , Vitrectomía/métodos , Cuerpo Vítreo/cirugía , Condroitinasas y Condroitín Liasas/administración & dosificación , Colagenasas/administración & dosificación , Endopeptidasas/administración & dosificación , Fibrinolisina/administración & dosificación , Humanos , Hialuronoglucosaminidasa/administración & dosificación , Cuidados Intraoperatorios/métodos , Activador de Tejido Plasminógeno/administración & dosificación , Activador de Plasminógeno de Tipo Uroquinasa/administración & dosificaciónRESUMEN
Enzymatic manipulation of the vitreous and vitreoretinal juncture is currently in the process of being evaluated in many centers around the world. The goals of such manipulation are either to disinsert the posterior hyaloid from the retina surface in an atraumatic, very clean, cleavage plane or, at this point, to try to disinsert the peripheral vitreous from the neurosensory retina. In addition, enzymatic manipulation of the central vitreous in terms of liquefaction has also been evaluated. Although this is certainly the beginning of this type of vitreal surgery, adjuvant or alternative, it does appear to be a new and exciting area of vitreoretinal surgery.